Skip to content
AnalystLens

Merck Annual Report (Amendment), Year Ended Dec 31, 1995

Filing Date
Filed June 26, 1996
Period End
December 31, 1995
Security
MRK
In the record · 2016–202610-K1210-Q338-K87

MRK filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 87 current reports (8-K) between 2016 and 2026.

  1. Impairment8-K · Feb ’17Feb ’17
  2. Restructuring8-K · Apr ’19Apr ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Restructuring8-K · Jul ’25Jul ’25

Summary

Summary of the 10-K/A filed June 26, 1996. Cited figures are marked; the original filing is the authoritative source.

The document provided is not a Merck & Co. (MRK) 10-K filed June 26, 1996.

It is Amendment No. 1 to Schering-Plough Corporation's Form 10-K for fiscal year 1995, dated June 14, 1996. Its only purpose is to attach the Form 11-K annual report for the Schering-Plough Employees' Savings Plan (Exhibit 28(b)). It contains no operating results, revenue, earnings, pipeline, or balance sheet data for either company, so it cannot support an investment analysis of Merck or of Schering-Plough as an operating business.

The analysis below covers only the savings plan's financial statements. Investors looking for Merck's 1995 annual results should obtain Merck's own 10-K. At December 31, 1995, the savings plan held net assets available for benefits of $179.9 milliona, up from $133.7 million a year earlier, an increase of $46.3 million (about 35%).

Total additions were $58.7 millionb, made up of $40.8 million of investment income (including $29.9 million of net appreciation) and $17.9 million of participant contributions. Benefit payments were $12.4 million. Schering-Plough common stock, held through the Schering-Plough Stock Fund, was the largest single holding at $57.8 million, versus $36.9 million in 1994.

Vanguard registered investment company shares totaled $116.5 millionc. The plan had 9,437 participants and beneficiaries at year end. The filing has internal inconsistencies.

The narrative in Exhibit II describes the plan's net assets as of December 31, 1994 and an increase of $16,336,749,d with total income of $22,055,393. These figures do not match the audited statements, which show a 1995 increase of $46,277 thousand and year-end 1995 net assets of $179,927 thousand. The audited statements should be treated as authoritative, and the narrative appears to be carried over from an earlier year's report.

Key Highlights

  1. Document identity: this is Schering-Plough Corporation Form 10-K/A (Amendment No. 1) for FY1995, dated June 14, 1996, which attaches a Form 11-K for the employee savings plan. It is not a Merck & Co. 10-K, and it contains no Merck financial data.
  2. Plan net assets rose to $179.9 million at December 31, 1995, from $133.7 million at year-end 1994, an increase of $46.3 million or roughly 35%.
  3. Investment-driven growth: net appreciation of $29.9 million and interest and dividends of $10.9 million together made up most of the increase. Participant contributions were $17.9 million, and benefit payments were $12.4 million.
  4. Concentration in company stock: the Schering-Plough Stock Fund was $57.8 million, about 32% of plan assets. Its cost basis was $28.7 million, implying about $29 million of unrealized gain.
  5. Diversified Vanguard holdings: registered investment company shares totaled $116.5 million across seven funds, led by the Windsor Fund ($51.2 million) and the Money Market Reserves U.S. Treasury Portfolio ($28.0 million).
  6. Participation: 9,437 participants and beneficiaries at year end 1995. Deloitte & Touche LLP issued an unqualified opinion dated June 14, 1996.
  7. Internal inconsistency: the narrative in Exhibit II cites different figures for the plan's net assets and increase in net assets than the audited financial statements. The audited figures should be relied on.

Frequently Asked Questions

  1. Is this filing Merck's 1995 annual report on Form 10-K?

    No. The filing is Schering-Plough Corporation's Form 10-K/A Amendment No. 1 for fiscal 1995, which attaches the Form 11-K annual report for its Employees' Savings Plan. It contains no Merck financial information. Merck's own 10-K should be consulted for its results.

  2. How large was the Schering-Plough savings plan at the end of 1995?

    Net assets available for benefits were $179.9 million at December 31, 1995, up from $133.7 million at December 31, 1994. The increase came mainly from investment gains and participant contributions, net of benefit payments.

  3. How much of the plan was invested in Schering-Plough stock?

    The Schering-Plough Stock Fund held $57.8 million at year-end 1995, about 32% of total plan assets. This was up from $36.9 million in 1994, and the fund's market value was roughly twice its original cost of $28.7 million.

  4. Does this filing reveal anything about Schering-Plough's business performance or financial health?

    No. The filing covers only the employee savings plan and does not include the company's income statement, balance sheet, product information, or outlook. Those items would appear in Schering-Plough's full 10-K for 1995.